Company Filing History:
Years Active: 1994-1998
Title: John Aris: Innovator in Monoclonal Antibodies
Introduction
John Aris is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for diagnosing autoimmune diseases.
Latest Patents
One of his latest patents involves monoclonal antibodies to nucleolar protein. This invention relates to a hybridoma cell line that produces a monoclonal antibody which cross-reacts with both yeast and human fibrillarin. The diagnostic kits described in this patent are useful in diagnosing diseases such as scleroderma. Another significant patent focuses on nucleic acid sequences that code for and express human fibrillarin. Substantially pure nucleic acid sequences coding for human fibrillarin have been identified and isolated. The isolated material is used to generate the protein in vitro, which is then utilized to identify autoimmune antibodies in patients suffering from scleroderma.
Career Highlights
John Aris is affiliated with The Rockefeller University, where he continues to advance research in his field. His work has garnered attention for its potential to improve diagnostic methods for autoimmune diseases.
Collaborations
He has collaborated with notable scientists, including Gunter Blobel, enhancing the impact of his research through shared expertise.
Conclusion
John Aris is a prominent figure in the field of biotechnology, with innovative patents that contribute to the understanding and diagnosis of autoimmune diseases. His work at The Rockefeller University exemplifies the importance of research in advancing medical science.